NCPA submitted comments to the Nebraska Unicameral Legislature’s Banking, Commerce and Insurance Committee in response to Legislative Resolution 431, which proposed an interim study on the pharmaceutical supply chain. Our comments focused on the need for PBM reform and transparent, cost-based pharmacy reimbursement. “With PBM issues well studied in many other states, we urge the Unicameral to transition quickly towards substantive action for the sake of independent pharmacies and the patients they serve in Nebraska,” wrote Joel Kurzman, NCPA director of state government affairs.
NCPA
